Contact Supplier

Contact Supplier

To get in touch with BioGenes working for greater German-Japanese co-operation in biologics at BioJapan Expo, simply fill out the form below.

Subscribe to Supplier

Subscribe to Supplier

BioGenes working for greater German-Japanese co-operation in biologics at BioJapan Expo

news-releasesBioGenes GmbH
September 27th 2018

Berlin, Germany: – Leading force in host cell protein (HCP) assay development, BioGenes GmbH, will be returning to the upcoming 20th BioJapan Expo and networking event in Yokohama to foster greater co-operation with Japanese partners.

BioGenes will be an exhibitor at the event with its stand at D35-06 within the German Pavilion showcasing its complete panel of products and services for companies involved in drug development, testing and quality control of biologics and biosimilars.

Marketing and Sales Manager, Dr. Marieke Mohr, will represent BioGenes at the BioJapan expo.

HCP and PK testing

The BioGenes display will highlight its recent advances in its host cell protein (HCP) kits and ELISA testing services and their applications in quality control of biological production. Offerings include custom antibody development (pAbs, mAbs, anti-IDs), custom ELISA development and kit production, HCP assays and analytical services.

BioGenes will also highlight its recently developed enhanced immunogenicity and pharmacokinetic (PK) testing tools and services, encompassing custom development of immunogenicity- and PK assays and corresponding antibodies.

New synergies

“This is the second time we have attended BioJapan, after our initial appearance in 2017,” noted Dr. Mohr.

“We are returning because this has proved a fine platform for fostering business contacts and partners in the Asian market, especially in Japan,” she added.

“I am particularly looking forward to speaking at the lunch sponsored by the German Export Initiative on Day Two on ‘Developing shared solutions! How German-Japanese cooperation can achieve potential synergy effect’, said Dr. Mohr.

“I hope to show how there are some very promising areas for partnership and joint enterprise in the fields of development and testing of new therapeutics, biologics and biosimilars,” she concluded.

About BioGenes GmbH

BioGenes GmbH (BioGenes) is an acknowledged global leader in host cell protein (HCP) assay development and a recognized partner of pharmaceutical companies all over the world. The Berlin-based company specializes in highly sophisticated and customized antibody and immunoassay development and is an experienced and reliable partner for process development improvements in all areas of quality control, diagnostics and drug discovery.

BioGenes is known as a trusted and experienced expert in immunoassay, 2D electrophoresis and antibody development with a business strategy focused on driving forward innovations for customers and building new strategic partnerships aimed at cementing its market leadership in host cell assay development.

BioGenes was founded in 1992 by Dr. Alexander Knoll (Managing Director) and Dr. Sergej Ovodov (Scientific Director), who is now sole owners following a management buyout in October 2015. Headquartered in Berlin, the company has a workforce numbering more than 50 people, most of them scientists.

The company maintains long-term relationships with research institutes, universities and biotech and pharmaceutical companies, including eight of the ten largest pharmaceutical companies in the world.

About BioJapan 2018

Founded in 1986, BioJapan now bills itself as ‘Asia’s Premier Partnering Event for the Global Biotechnology Industry’.

Over more than two decades, the BioJapan Expo has played an increasingly important role in facilitating interaction between Japanese and global companies/organizations and stimulating new business opportunities in what is now an annual event.

The 20th BioJapan Expo is a three-day event opening October 10 at the Pacifico Center in the port city of Yokohama. It is expected to draw top business development, licensing, and alliance management professionals, R&D personnel, and biotech company executives representing some 900 organizations from more than 30 nations. They will participate in some 9,000 business meetings and sessions over the course of the three days.

The event is organized by JTB Communication, with more information available at:

Contact BioGenes GmbH

Simply fill out the form below to contact BioGenes GmbH now.

Send BioGenes GmbH a Message